福克斯新闻数字频道获悉，马卡里与白宫之间“并无嫌隙”
2026年5月12日 美国东部时间下午1:23 / 福克斯新闻
作者：阿什利·J·迪梅拉、凯特琳·卡拉莱
FDA局长马蒂·马卡里医生参加《玛丽亚早间秀》，推动精简繁文缛节、加快救命药物审批、披露隐藏的新冠疫苗数据并降低飙升的处方药成本。
【新功能】您现在可以收听福克斯新闻文章了！
收听本文
时长3分钟
一名白宫官员告诉福克斯新闻数字频道，美国食品药品监督管理局（FDA）局长马蒂·马卡里将于周二辞职。
该官员表示，马卡里的辞职与“FDA内部的流程问题”有关，而非特定事件，并称唐纳德·特朗普总统与这位即将离任的局长之间“并无嫌隙”。据这位白宫官员透露，美国卫生与公众服务部部长小罗伯特·F·肯尼迪推动了马卡里的辞职。
福克斯新闻数字频道获悉，负责食品事务的FDA副局长凯尔·迪亚曼蒂斯将担任代理局长。
特朗普提名马蒂·马卡里医生出任FDA局长
马卡里的辞职此前，他因处理一款备受争议的堕胎药物问题与反堕胎组织的冲突不断升级，这场争执可能会对共和党在中期选举中的选情造成政治影响。（安德鲁·哈尼克/盖蒂图片社）
特朗普在周二下午晚些时候对媒体发表讲话时，称马卡里是个“很棒的人”，也是他的朋友。
“他是一名出色的医生，此前遇到了一些困难，但他会继续前行，并且会做得很好，”特朗普在离开白宫前往中国进行高风险访问时对媒体表示。
特朗普在周二的Truth Social帖子中补充道：“我要感谢马蒂·马卡里医生在FDA期间出色完成了工作。在他的领导下，我们取得了诸多成就。他工作勤奋，受到所有人的尊重，未来在医学领域必将拥有辉煌的职业生涯。才华横溢的凯尔·迪亚曼塔斯将出任代理局长一职。”
据近期媒体报道，马卡里的辞职是在反堕胎倡导者和政府批评者不断施压的背景下发生的，他们对马卡里处理多起备受瞩目的FDA决策以及他放缓推进“MAHA倡议”感到不满。
《华尔街日报》周五报道称，据三位知情人士透露，总统 reportedly 已经批准了解雇马卡里的计划，理由是马卡里在堕胎和药物政策方面的处理方式。
“我一直在关注相关报道，但我对此一无所知，”当天当被记者问及马卡里是否会被解雇时，特朗普如此回应。
内阁改组持续：诺埃姆离职、邦迪被解雇后，下一个压力山大的会是谁？
马卡里的辞职原定于周三，也就是一天后，他将出席参议院拨款委员会的听证会。
尽管白宫官员表示马卡里的辞职并非由特定事件引发，但他在FDA任职期间，一直处于堕胎药物米非司酮（又称“堕胎药”）、疫苗政策和药物审批等争议的中心，这让反堕胎活动人士和与“MAHA”结盟的批评者感到沮丧，他们认为该机构在推进特朗普的医疗议程方面行动过于缓慢。
特朗普当选后，反堕胎组织和选民曾寄希望于本届政府废除拜登时期允许在线开具米非司酮处方并通过邮寄配送的规定。但FDA保留了这些规定，且在马卡里的领导下，去年该机构批准了这款药物的新仿制药版本。
“特朗普总统和卫生与公众服务部部长肯尼迪必须立即结束这一切，罢免马卡里局长，叫停邮寄堕胎药物的计划，并将这些杀害婴儿的药物从市场上撤下，”反堕胎组织“生命行动”主席莱拉·罗斯在马卡里辞职前对福克斯新闻数字频道表示。
米非司酮暂时仍可通过邮寄渠道购买，FDA面临6个月审查期限
“特朗普总统和卫生与公众服务部部长肯尼迪必须立即结束这一切，罢免马卡里局长，叫停邮寄堕胎药物的计划，并将这些杀害婴儿的药物从市场上撤下，”反堕胎组织“生命行动”主席莱拉·罗斯在马卡里辞职前对福克斯新闻数字频道表示。（安德鲁·哈尼克/盖蒂图片社）
“马卡里最终把事情搞得一团糟，”一位特朗普政府官员五月初对福克斯新闻数字频道表示，称这位局长的言论和行动无异于在告诉“每一位反堕胎倡导者，他们的担忧都被当作耳旁风”。
“他的傲慢令人震惊，”这位官员谈及这位FDA局长时补充道。
顶级反堕胎组织披露特朗普政府第二任期议程， amid“堕胎恐慌造势”
马卡里的离职是今年一系列高调离职事件中的最新一起，此前包括前国土安全部部长克里斯蒂·诺埃姆和前司法部长帕姆·邦迪。（安德鲁·哈尼克/盖蒂图片社）
“生命行动”主席玛乔丽·丹嫩费瑟五月初对《华尔街日报》表示，谈及近年来堕胎问题在共和党选民中关注度下降时，“特朗普才是问题所在”。
她表示，如果共和党候选人希望获得该组织在中期选举和2028年总统大选中提供的1.6亿美元支持，就必须承诺“在国家层面采取反堕胎行动”。
密苏里州共和党参议员乔希·霍利周二下午在X平台上回应称，马卡里的辞职是“好消息”。
“马卡里医生对反堕胎运动造成了独一无二的破坏，”霍利在X平台上写道。“他试图将支持堕胎权的律师安插在关键岗位上。他拖延了对堕胎药物米非司酮至关重要的审查。他凭借自由裁量权批准了一款新的堕胎药物，而数据显示，每10名女性中就有1人会因此前往急诊室。他排挤反堕胎领袖，多次阻挠国会。他的辞职为FDA提供了重启的机会。”
点击此处下载福克斯新闻APP
马卡里的离职是今年一系列高调离职事件中的最新一起，此前包括前国土安全部部长克里斯蒂·诺埃姆和前司法部长帕姆·邦迪。
福克斯新闻数字频道的保罗·施泰因豪泽对本文亦有贡献。
阿什利·J·迪梅拉为福克斯新闻数字频道报道政治新闻。
Trump’s FDA boss resigning as admin taps next acting leader
There is ‘no bad blood’ between Makary and the White House, Fox News Digital learned
May 12, 2026 1:23pm EDT / Fox News
By Ashley J. DiMella, Katelyn Caralle
FDA Commissioner Dr. Marty Makary joins ‘Mornings with Maria’ to unveil the push to slash red tape, accelerate life-saving drug approvals, expose hidden COVID vaccine data and cut soaring prescription costs.
NEW You can now listen to Fox News articles!
Listen to this article
3 min
Food and Drug Administration (FDA) Commissioner Marty Makary is resigning from his position Tuesday, a White House official told Fox News Digital.
The official said that Makary’s resignation has to do with “process at the FDA” and not a specific issue, and said there is “no bad blood” between President Donald Trump and the outgoing commissioner. Health and Human Services Secretary Robert F. Kennedy Jr. pushed for Makary’s resignation, according to the White House official.
Kyle Diamantis, FDA deputy commissioner for Food, will serve as acting commissioner, Fox News Digital learned.
TRUMP PICKS DR. MARTY MAKARY AS FOOD AND DRUG ADMINISTRATION COMMISSIONER
Makary’s resignation follows an escalating clash with pro-life groups over the handling of a controversial abortion drug, a fight that could carry political consequences for Republicans heading into the midterms.(Andrew Harnik/Getty Images)
Trump called Makary a “great guy” who is a friend of his in remarks to the media later on Tuesday afternoon.
“He’s a great doctor and he was having some difficulty, but he’s going to go on and he’s going to do well,” Trump told the media as he departed the White House for a high-stakes trip to China.
“I want to thank Dr. Marty Makary for having done a great job at the FDA,” Trump added in a Truth Social post on Tuesday. “So much was accomplished under his leadership. He was a hard worker, who was respected by all, and will go on to have an outstanding career in Medicine. Kyle Diamantas, a very talented person, will be put in the Acting position.”
Makary’s resignation followed mounting pressure from pro-life advocates and administration critics who had grown frustrated with his handling of several high-profile FDA decisions and claims he has slow-rolled MAHA initiatives, according to media reports in recent weeks.
The Wall Street Journal reported on Friday that the president had reportedly already signed off on a plan to fire Makary, citing three familiar sources who cited Makary’s handling of abortion and drug policy.
“I’ve been reading about it, but I know nothing about it,” Trump said the same day after he was asked by reporters if Makary would be fired.
TRUMP CABINET SHAKEUP EXPANDS AFTER NOEM EXIT, BONDI FIRING — WHO’S UNDER PRESSURE NEXT?
The resignation comes one day before Makary was set to testify in front of the Senate Appropriations Committee Wednesday.
Though Makary’s resignation is not attributable to a specific issue, according to the White House official, his tenure atop the FDA has put him at the center of fights over abortion drug mifepristone – otherwise known as the “abortion pill” – vaccine policy and drug approvals, frustrating pro-life activists and MAHA-aligned critics who argued the agency has moved too slowly to carry out Trump’s health agenda.
When Trump was elected, pro-life groups and voters were banking on the administration rolling-back Biden-era rules that allowed mifepristone to be prescribed online and shipped through the mail. But the FDA left those rules intact and last year, under Makary’s leadership, approved a new generic version of the pill.
“President Trump and Health and Human Services Secretary Kennedy must end this now, remove Commissioner Makary, stop the mail order abortion scheme, and pull these child-killing drugs from the market,” said Live Action president Lila Rose to Fox News Digital ahead of Makary’s resignation.
ABORTION PILL MIFEPRISTONE STAYS AVAILABLE BY MAIL FOR NOW AS FDA FACES 6-MONTH REVIEW DEADLINE
“President Trump and Health and Human Services Secretary Kennedy must end this now, remove Commissioner Makary, stop the mail order abortion scheme, and pull these child-killing drugs from the market,” said Live Action president Lila Rose to Fox News Digital ahead of Makary’s resignation.(Photo by Andrew Harnik/Getty Images)
“What a mess Makary turned out to be,” a Trump administration official told Fox News Digital earlier in May, claiming the commissioners’ comments and actions have told “every pro-life advocate their concerns are an afterthought.”
“The arrogance is stunning,” they added of the FDA commissioner.
TOP PRO-LIFE GROUPS REVEAL AGENDA FOR SECOND TRUMP ADMINISTRATION AMID ‘ABORTION FEARMONGERING’
Makary’s exit follows a series of high profile departures this year, including former Homeland Security Secretary Kristi Noem and former Attorney General Pam Bondi.(Andrew Harnik/Getty Images)
Susan B. Anthony Pro-Life America President Marjorie Dannenfelser told the Wall Street Journal earlier in May that “Trump is the problem,” when it comes to the abortion issues falling off for the GOP in recent years.
And if candidates want her group’s $160 million in the midterms and 2028 presidential election, she said they must commit “to pro-life action at the national level.”
Republican Missouri Sen. Josh Hawley said the resignation was “welcome news” in reaction on X Tuesday afternoon.
“Dr. Makary was uniquely destructive to the prolife movement,” Hawley wrote on X. “He attempted to place pro-abortion lawyers in key positions. He slow walked a vitally necessary review of the abortion drug mifepristone. He used his discretion to approve a new abortion drug when the data shows it sends 1 in 10 women to the emergency room. He froze out prolife leaders and repeatedly stonewalled Congress. His resignation is an opportunity for the FDA to reset.”
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
Makary’s exit follows a series of high profile departures this year, including former Homeland Security Secretary Kristi Noem and former Attorney General Pam Bondi.
Fox News Digital’s Paul Steinhauser contributed to this report.
Ashley J. DiMella reports on politics for Fox News Digital.
发表回复